Liechtenstein - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes
Since 2014, Liechtenstein Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes increased 27.3% year on year. In 2019, the country was ranked number 4 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes at €30.38 Per Capita. Liechtenstein is overtaken by France, which was number 3 with €30.64 Per Capita and is followed by Cyprus with €22.64 Per Capita. Slovenia ranked the highest with €84.89 Per Capita in 2019, -0.2% compared to 2018. Liechtenstein witnessed the best average annual growth at +27.3% per year, while Netherlands witnessed the worst performance at -18.4% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 30.38 |
2018 | 34.51 |
2017 | 16.09 |
2016 | 9.06 |
2015 | 9.13 |
How does Liechtenstein rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes?
# | 20 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Slovenia
|
84.89 | 2019 | -0.2 % | +2.2 % | View data |
2 |
#2
Switzerland
|
71.18 | 2019 | -9.9 % | +18.5 % | View data |
3 |
#3
France
|
30.64 | 2019 | -10.4 % | -15.1 % | View data |
4 |
#4
Liechtenstein
|
30.38 | 2019 | -12.0 % | +27.3 % | View data |
5 |
#5
Cyprus
|
22.64 | 2019 | -5.3 % | -11.0 % | View data |